3-V Biosciences Lands $20,000,000 Series C Funding

  • Feed Type
  • Date
    6/24/2013
  • Company Name
    3-V Biosciences
  • Mailing Address
    1050 Hamilton Court Menlo Park, CA 94025
  • Company Description
    3-V Biosciences was founded by The Column Group (TCG) and Kleiner Perkins Caulfield & Byers (KPCB) in March 2007. In April 2007, the original laboratory was opened in Zürich, Switzerland in close proximity to the company’s founders at the ETH (Swiss Federal Institute of Technology) and the University of Zürich.
  • Website
    http://www.3vbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds from the financing will be used to advance 3-V’s lead oncology candidate into a Phase 1 clinical trial and to conduct ongoing preclinical studies of multiple virology leads generated by the company’s integrated drug discovery process.
  • M&A Terms
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    New Enterprise Associates

By posting a comment, you agree to our terms and conditions.